The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((1-methyl-4-(4-phenylthiazol-2-yl)piperidin-4-yl)methyl)-3-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide ID: ALA4525406
Cas Number: 1314890-51-1
PubChem CID: 69950064
Max Phase: Preclinical
Molecular Formula: C26H24F3N5O2S
Molecular Weight: 527.57
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCC(CNC(=O)c2cccc(-c3noc(C(F)(F)F)n3)c2)(c2nc(-c3ccccc3)cs2)CC1
Standard InChI: InChI=1S/C26H24F3N5O2S/c1-34-12-10-25(11-13-34,24-31-20(15-37-24)17-6-3-2-4-7-17)16-30-22(35)19-9-5-8-18(14-19)21-32-23(36-33-21)26(27,28)29/h2-9,14-15H,10-13,16H2,1H3,(H,30,35)
Standard InChI Key: BQFISAUAZNJOEG-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
7.5239 -5.2829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9367 -5.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3451 -5.2804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2350 -6.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2350 -7.2227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9403 -7.6271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6456 -7.2227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6456 -6.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1574 -5.1953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3257 -4.3916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6132 -3.9831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0048 -4.5345 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.7068 -5.2853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2960 -4.5789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4788 -4.5813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7025 -3.8699 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9403 -8.4443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0717 -3.8717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2553 -3.8738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8480 -4.5833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2631 -5.2921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0782 -5.2865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8464 -3.1708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1769 -2.4234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5682 -1.8781 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8615 -2.2885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0335 -3.0874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1141 -1.9581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0667 -4.0563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7294 -4.5364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4743 -4.2024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5578 -3.3886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8903 -2.9099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1480 -3.2466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0265 -1.1456 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.4542 -2.4402 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.3172 -1.7446 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
4 2 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 2 1 0
3 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 3 1 0
1 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
6 17 1 0
15 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 15 1 0
23 24 2 0
24 25 1 0
25 26 1 0
26 27 2 0
27 23 1 0
19 23 1 0
26 28 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
10 29 1 0
28 35 1 0
28 36 1 0
28 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 527.57Molecular Weight (Monoisotopic): 527.1603AlogP: 5.27#Rotatable Bonds: 6Polar Surface Area: 84.15Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 8.22CX LogP: 5.51CX LogD: 4.63Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.37Np Likeness Score: -1.47
References 1. Asfaha Y, Schrenk C, Alves Avelar LA, Hamacher A, Pflieger M, Kassack MU, Kurz T.. (2019) Recent advances in class IIa histone deacetylases research., 27 (22): [PMID:31561937 ] [10.1016/j.bmc.2019.115087 ]